glycyl-prolyl-arginyl-valyl-valyl-glutamic acid has been researched along with fibrinogen in 4 studies
*Fibrinogen: Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. [MeSH]
*Fibrinogen: Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. [MeSH]
| Studies (glycyl-prolyl-arginyl-valyl-valyl-glutamic acid) | Trials (glycyl-prolyl-arginyl-valyl-valyl-glutamic acid) | Recent Studies (post-2010) (glycyl-prolyl-arginyl-valyl-valyl-glutamic acid) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 6 | 1 | 0 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argiriou, S; Dempfle, CE; Heene, DL; Kucher, K; Müller-Peltzer, H; Rübsamen, K | 1 |
| Hamano, A; Mimuro, J; Sakata, Y; Tanaka, S; Ueno, Y; Umeda, M | 1 |
| Chtcheglova, LA; Dietler, G; Gruber, HJ; Haeberli, A; Vogel, M | 1 |
| Elgue, G; Larsson, R; Nilsson, B; Olsson, P; Sanchez, J | 1 |
4 other study(ies) available for glycyl-prolyl-arginyl-valyl-valyl-glutamic acid and fibrinogen
| Article | Year |
|---|---|
Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.
Topics: Adult; alpha-2-Antiplasmin; Ancrod; Biopolymers; Calcium Chloride; Chromatography, Gel; Enzyme Activation; Factor XIII; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Fibrinopeptide A; Hirudins; Humans; Infusions, Intravenous; Macromolecular Substances; Male; Middle Aged; Peptide Fragments; Plasminogen; Recombinant Proteins; Solubility; Thrombin; Tissue Plasminogen Activator | 2000 |
Latex immunoturbidimetric assay for soluble fibrin complex.
Topics: Antibodies, Monoclonal; Antithrombin III; Autoanalysis; Calibration; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoassay; Latex; Nephelometry and Turbidimetry; Peptide Fragments; Peptide Hydrolases; ROC Curve; Sensitivity and Specificity; Solubility | 2005 |
Kinetics of the interaction of desAABB-fibrin monomer with immobilized fibrinogen.
Topics: Biopolymers; Biosensing Techniques; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Kinetics; Peptide Fragments; Protein Binding | 2006 |
Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
Topics: Adsorption; Blood Coagulation; Factor XII; Fibrin; Fibrinogen; Glass; Heparin; Humans; Peptide Fragments; Polystyrenes; Prekallikrein; Sodium; Surface Properties; Thrombin | 2008 |